^
Association details:
| Biomarker: | EGFR-RAD51 fusion |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug Class: | EGFR inhibitor |
| Direction: | Resistant |
Evidence:
Source:
Title:
P76.81 - Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma harboring EGFR–RAD51 Fusion: A Brief Report
Published date:
01/12/2021
Excerpt:
Totally 2 patients harbored de novo EGFR-RAD51 fusion….both were diagnosed with metastatic lung adenocarcinoma and had poor progression-free survival to EGFR-TKIs.
